Home Newsfeeds Needham Reiterates Buy on Monday.Com, Maintains $230 Price Target

Needham Reiterates Buy on Monday.Com, Maintains $230 Price Target

Needham analyst Scott Berg reiterates Monday.Com (NASDAQ:MNDY) with a Buy and maintains $230 price target.

byBenzinga Newsdesk

February 14, 2023

1 minute read

Needham analyst Scott Berg reiterates Monday.Com (NASDAQ:MNDY) with a Buy and maintains $230 price target.

Analyst Ratings

Analyst Expectations for Avadel Pharmaceuticals’s Future

By Benzinga Insights

May 2, 1:01 PM

Within the last quarter, Avadel Pharmaceuticals (NASDAQ:AVDL) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

AVDL

TOP Ships FY EPS $(3.03) Down From $2.80 YoY, Sales $80.66M Up From $56.37M YoY

By Happy Mohamed

March 1, 9:33 AM

TOP Ships (NASDAQ: TOPS) reported quarterly losses of $(3.03) per share. This is a 208.21 percent decrease over earnings of $2.80 per share from the same period last year. The company reported $80.66 million in sales this quarter. This is a 43.09 percent increase over sales of $56.37 million the same period last year.

TOPS

Republic Services Q2 EPS $1.32 Beats $1.18 Estimate, Sales $3.41B Beat $3.29B Estimate

By Benzinga Newsdesk

August 4, 5:47 PM

Republic Services (NYSE:RSG) reported quarterly earnings of $1.32 per share which beat the analyst consensus estimate of $1.18 by 11.86 percent. This is a 21.1 percent increase over earnings of $1.09 per share from the

RSG

PAVmed Provides Additional Details For Upcoming Stock Dividend To Shareholders; PAVmed Shareholders As Of January 15, 2024 Will Participate In Distribution Of ~3.3M Shares Of Lucid Common Stock

By Benzinga Newsdesk

December 11, 10:18 AM

PAVmed shareholders as of January 15, 2024 will participate in distribution of approximately 3.3 million shares of Lucid common stockNEW YORK, Dec. 11, 2023 /PRNewswire/ -- PAVmed Inc. (NASDAQ:PAVM, PAVMZ)))

LUCD

Needham Reiterates Buy on Monday.Com, Maintains $230 Price Target

Related Posts

Analyst Expectations for Avadel Pharmaceuticals’s Future

TOP Ships FY EPS $(3.03) Down From $2.80 YoY, Sales $80.66M Up From $56.37M YoY

Republic Services Q2 EPS $1.32 Beats $1.18 Estimate, Sales $3.41B Beat $3.29B Estimate

PAVmed Provides Additional Details For Upcoming Stock Dividend To Shareholders; PAVmed Shareholders As Of January 15, 2024 Will Participate In Distribution Of ~3.3M Shares Of Lucid Common Stock